HOMEBIOGAS LTD (IL:HMGS)
TASE:HMGS
Want to see IL:HMGS full AI Analyst Report?
Top Page
Homebiogas
(TASE:HMGS)
Select Model
Select Model
Rating:50Neutral
Price Target:
70.00
▼(-48.68% Downside)
Action:Reiterated
Date:06/24/26
The score is held down primarily by weak financial performance—large ongoing losses, persistent cash burn, and significant equity erosion despite modest leverage. Technical indicators are moderately supportive (price above short-term averages and positive MACD), but valuation remains constrained by negative earnings and no dividend yield data.
Positive Factors
Revenue growth & gross margin expansion
Revenue growth paired with a large gross margin improvement indicates improving unit economics and product-market traction. Sustained margin expansion reduces the revenue required to reach breakeven and improves long-term scalability if the company maintains cost discipline while growing volumes.
Negative Factors
Very large operating and net losses
Deep negative margins indicate the core business is not yet covering operating costs; sustained large losses will continue to erode capital and limit reinvestment. Without clear path to profitability, the business depends on structural margin improvements or faster revenue scale to be viable long term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth & gross margin expansion
Revenue growth paired with a large gross margin improvement indicates improving unit economics and product-market traction. Sustained margin expansion reduces the revenue required to reach breakeven and improves long-term scalability if the company maintains cost discipline while growing volumes.
Read all positive factors
Homebiogas (HMGS) vs. iShares MSCI Israel ETF (EIS)
Market Cap
₪29.24M
Dividend YieldN/A
Average Volume (3M)182.00K
Price to Earnings (P/E)―
Beta (1Y)-0.22
Revenue Growth2.77%
EPS Growth65.92%
CountryIL
Employees69
SectorEnergy
Sector Strength52
IndustryRenewable Utilities
Share Statistics
EPS (TTM)-0.15
Shares Outstanding43,975,130
10 Day Avg. Volume222,381
30 Day Avg. Volume182,002
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)3.96
Price to Sales (P/S)3.54
P/FCF Ratio-4.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Homebiogas Business Overview & Revenue Model
Company Description
HomeBiogas LTD develops, produces, and markets innovative biogas systems that convert organic waste into clean energy. These solutions serve a broad international clientele, including private homes, agricultural businesses, commercial entities, an...
How the Company Makes Money
null...
Homebiogas Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
52
Neutral
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 3.13M | 2.63M | 4.83M | 4.70M | 2.48M |
| Gross Profit | 899.53K | 384.00K | 1.55M | 1.34M | 234.00K |
| EBITDA | -3.76M | -8.23M | -9.91M | -14.00M | -7.64M |
| Net Income | -4.14M | -9.42M | -11.34M | -15.16M | -8.31M |
Balance Sheet | |||||
| Total Assets | 5.23M | 8.21M | 19.43M | 19.62M | 33.58M |
| Cash, Cash Equivalents and Short-Term Investments | 1.95M | 2.84M | 9.14M | 11.20M | 26.05M |
| Total Debt | 391.08K | 470.00K | 1.95M | 1.64M | 1.99M |
| Total Liabilities | 2.16M | 3.23M | 5.39M | 5.23M | 5.49M |
| Stockholders Equity | 2.79M | 4.93M | 14.04M | 14.39M | 28.09M |
Cash Flow | |||||
| Free Cash Flow | -2.44M | -5.54M | -11.13M | -12.77M | -10.72M |
| Operating Cash Flow | -2.43M | -4.51M | -10.58M | -11.57M | -8.33M |
| Investing Cash Flow | 169.95K | -847.00K | -571.00K | -1.13M | -2.49M |
| Financing Cash Flow | 1.02M | -639.00K | 9.28M | -419.00K | 28.77M |
Homebiogas Technical Analysis
Neutral
136.40
Price Trends
59.21
Positive
69.34
Negative
103.89
Negative
Market Momentum
3.58
Negative
56.29
Neutral
43.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HMGS, the sentiment is Neutral. The current price of 136.4 is above the 20-day moving average (MA) of 58.86, above the 50-day MA of 59.21, and above the 200-day MA of 103.89, indicating a neutral trend. The MACD of 3.58 indicates Negative momentum. The RSI at 56.29 is Neutral, neither overbought nor oversold. The STOCH value of 43.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IL:HMGS.
Homebiogas Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
56 Neutral | ₪8.93B | -6,775.44 | ― | ― | ― | ― | |
54 Neutral | ₪4.65B | -28.41 | ― | ― | -16.92% | -524.11% | |
50 Neutral | ₪29.24M | -1.49 | ― | ― | 2.77% | 65.92% | |
50 Neutral | ₪2.22B | -112.43 | ― | ― | ― | ― | |
47 Neutral | ₪3.87B | -13.75 | ― | ― | 71.02% | -254.33% |
* Energy Sector Average
IL:HMGS
Homebiogas
66.90
-57.40
-46.18%
IL:MSKE
Meshek Energy
1,213.00
843.70
228.46%
IL:PRIM
Prime Energy
4,601.00
3,208.00
230.29%
IL:ECNR
Econergy
6,125.00
2,776.00
82.89%
IL:SBEN
SHIKUN & BINUI ENERGY LTD
399.60
104.10
35.23%
IL:ZPRS
Zephyrus Wing Energies Ltd.
3,220.00
1,826.00
130.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.